`
`Trials@uspto.gov
`571-272-7822
`
`
`
`Paper No. 13
`Date Entered: August 31, 2016
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MYLAN PHARMACEUTICALS, Inc.,
`Petitioner,
`
`v.
`
`SENJU PHARMACEUTICAL CO., LTD.,
`Patent Owner.
`____________
`
`Case IPR2016-00626
`Patent 8,784,789 B2
`____________
`
`
`
`
`
`Before LORA M. GREEN, JACQUILINE WRIGHT BONILLA, and
`SUSAN L. C. MITCHELL, Administrative Patent Judges.
`
`MITCHELL, Administrative Patent Judge.
`
`DECISION
`Termination of the Proceeding
`37 C.F.R. §§ 42.72 and 42.74
`
`
`
`
`
`
`
`
`IPR2016-00626
`Patent 8,784,789 B2
`
`
`
`I. DISCUSSION
`On August 9, 2016, the parties filed a Joint Motion to Terminate this case
`(Paper 10), a true copy of the parties’ settlement agreement (Ex. 1035), and a
`request to treat the settlement agreement as business confidential information and
`kept separate under 37 C.F.R. § 42.74(c) (Paper 11).
`This case is still in its preliminary stages. On February 25, 2016, Petitioner,
`Mylan Pharmaceuticals, Inc., filed a Petition requesting an inter partes review of
`claims 1–11 of U.S. Patent No. 8,784,789 B2 (Ex. 1001, “the ’789 patent”).
`Paper 2. Patent Owner, Senju Pharmaceutical Co., Ltd., filed a Preliminary
`Response in this proceeding. Paper 8. We have not entered a decision on whether
`to institute an inter partes review.
`In the Joint Motion to Terminate this case, the parties represent that they
`have settled all of their disputes regarding the ’789 patent. Paper 10, 2.
`Specifically, the parties represent that the Confidential Settlement and License
`Agreement (“Agreement”) “ends all patent disputes between the parties, including
`this proceeding. Moreover . . . the Agreement resulted in the dismissal of the
`underlying civil action.” Id. at 3. Under these circumstances, we determine that it
`is appropriate to terminate this case without rendering any further decision. See
`37 C.F.R. § 42.72.
`
`II. ORDER
`In consideration of the foregoing, it is hereby:
`ORDERED that the parties’ request to treat the settlement agreement
`(Ex. 1035) as business confidential information under 37 C.F.R. § 42.74(c) is
`GRANTED; and
`FURTHER ORDERED that the Joint Motion to Terminate this case is
`GRANTED, and this case is hereby terminated.
`
`
`
`2
`
`
`
`IPR2016-00626
`Patent 8,784,789 B2
`
`
`
`For PETITIONER:
`
`Jitendra Malik
`Lance Soderstrom
`James Abe
`Joseph Janusz
`ALSTON & BIRD LLP
`jitty.malik@alston.com
`lance.soderstrom@alston.com
`james.abe@alston.com
`joe.janusz@alston.com
`
`
`
`For PATENT OWNER:
`
`Bryan Diner
`Justin Hasford
`Joshua Goldberg
`FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP
`bryan.diner@finnegan.com
`justin.hasford@finnegan.com
`joshua.goldberg@finnegan.com
`
`
`
`
`
`3